Nordic Capital investerar tillsammans med Astorg i Cytel, ett företag verksamt inom utformning av kliniska studier åt läkemedelsföretag
Cytel
is one of the leading global providers of clinical trial
design technology, biometric services and advanced analytics, focusing
on optimizing clinical trials and helping pharmaceutical companies to
unlock the full potential of their clinical and real-world data
Nordic Capital and Astorg will actively support
and accelerate Cytel’s next phase of growth and innovation, drawing on
their extensive experience of investing in healthcare and
technology
Read more